Europe Pain Management Devices Market was worth USD 0.92 billion in 2018 and is expected to grow at a CAGR of 7.9%, to reach USD 1.34 billion by 2023. Pain is caused due to the unpleasant sensory stimulation caused due to damage to the tissues by any means. It is majorly caused by injuries as well as in the case of diseases such as arthritis, ulcers, cancer and multiple sclerosis. Acute pain is caused for a very short period of time whereas chronic pain is persistent for extended time periods.
Several drugs and devices are available in the market to assist in pain management. These devices work by blocking the nerve stimulators by transmitting the unpleasant sensory experience to the brain. Neurostimulation devices, ablation devices, and analgesic infusion pumps are some of the pain management devices. Neurostimulators block pain by supplying certain frequencies of current to prevent the passage of signals.
Increase in demand for alternatives for pain management drugs which cause many side effects, a large number of patients with chronic diseases especially in geriatric population and technological advancements to develop better pain management devices are expected to drive the market. Increase in cancer patients and increase in neuropathic diseases are also boosting the pain management devices market. However, side effects associated with the use of these devices such as hypersensitivity and redness of skin and high manufacturing costs are restraining the market.
The pain management devices market is categorized based on device type, application, mode of purchase and region. On the basis of the device type, the market is categorized into neurostimulation devices, ablation devices, and analgesic infusion pumps. Neurostimulation devices are again categorized into Transcutaneous Electrical Nerve Stimulation devices and Spinal Cord Stimulation devices. Ablation devices are again categorized into Radiofrequency ablation devices and cryoablation devices. Analgesic infusion pumps are again categorized into intrathecal infusion pumps and external infusion pumps. Neurostimulation devices hold the largest market share due to their extensive usage in chronic pain management. On the basis of application, the market is categorized into Neuropathic pain, Facial pain and migraine, musculoskeletal pain, cancer pain and other pains. On the basis of mode of purchase, the market is categorized into over the counter purchase and prescription based purchase.
On the basis of region, the Europe pain management devices market is segmented into U.K, Germany, France, Spain and Italy. U.K leads the market in this region due to the presence of major players in this region.
Some of the major companies in the market are St. Jude Medical, Inc., Boston Scientific Corporation, Medtronic plc, Baxter international, Stryker corporation, Pfizer, Codman and Shurtleff, B Braun Melsungen AG and DJO Global LLC.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Device Type
5.1.1 Introduction
5.1.2 Neurostimulation Devices
5.1.2.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
5.1.2.2 Spinal Cord Stimulation (SCS) Devices
5.1.3 Ablation Devices
5.1.3.1 RF Ablation Devices
5.1.3.2 Cryoablation Devices
5.1.4 Analgesic Infusion Pumps
5.1.4.1 Intrathecal Infusion Pumps
5.1.4.2 External Infusion Pumps
5.1.5 Y-o-Y Growth Analysis, By Device Type
5.1.6 Market Attractiveness Analysis, By Device Type
5.1.7 Market Share Analysis, By Device Type
5.2 Application
5.2.1 Introduction
5.2.2 Neuropathic Pain
5.2.3 Musculoskeletal Pain
5.2.4 Facial Pain and Migraine
5.2.5 Cancer Pain
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
5.3 Mode of Purchase
5.3.1 Introduction
5.3.2 Over-the-Counter based
5.3.3 Prescription Based
5.3.4 Y-o-Y Growth Analysis, By Mode of Purchase
5.3.5 Market Attractiveness Analysis, By Mode of Purchase
5.3.6 Market Share Analysis, By Mode of Purchase
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Device Type
6.1.3.3 By Application
6.1.3.4 By Mode of Purchase
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Device Type
6.1.4.3 By Application
6.1.4.4 By Mode of Purchase
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device Type
6.1.5.3 By Application
6.1.5.4 By Mode of Purchase
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 St. Jude Medical, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Boston Scientific Corporation
8.3 Medtronic plc
8.4 Baxter international
8.5 Stryker corporation
8.6 Pfizer
8.7 Codman and Shurtleff
8.8 B Braun Melsungen AG
8.9 DJO Global LLC.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
